Vimarsana
Biggest News Aggregation in the World

Page 6 - Equity Consideration News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Equity Consideration. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Equity Consideration Today - Breaking & Trending Today

Cyber A.I. Group Announces the Engagement of Walter L. Hughes as Chief ... - Vimarsana News

Cyber A.I. Group Announces the Engagement of Walter L. Hughes as Chief ...

Cyber A.I. Group Announces the Engagement of Walter L. Hughes as Chief ...

 - Vimarsana News

You should read the following discussion along with our financial statements and the related notes included elsewhere in this Annual Report on Form 10-K. The following discussion contains... | April 14, 2023

My Size : Other Report or Announcement - Vimarsana News

My Size : Other Report or Announcement

Filed pursuant to Rule 424 Registration No. 333-269467 My Size, Inc. 2,572,832 Shares of Common Stock ... | February 11, 2023

Sun Pharma to Acquire Concert Pharmaceuticals, Advancing the Potential Treatment of Alopecia Areata - Jammu Kashmir Latest News | Tourism - Vimarsana News

Sun Pharma to Acquire Concert Pharmaceuticals, Advancing the Potential Treatment of Alopecia Areata - Jammu Kashmir Latest News | Tourism

  MUMBAI (Maharashtra) [India]/ Lexington [Kentucky], Jan 20: Sun Pharmaceutical Industries Limited (Reuters: SUN.BO ) (Bloomberg: SUNP IN) (NSE: SUNPHARMA) (BSE: 524715) (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) (“Concert”) today announced that they have executed a definitive agreement under which Sun Pharma will acquire all outstanding shares of Concert through a tender offer for an upfront payment of USD 8.00 per share of common stock in cash, or USD 576 million […]

Sun Pharma to Acquire Concert Pharmaceuticals | Advancing the Potential Treatment of Alopecia Areata - Vimarsana News

Sun Pharma to Acquire Concert Pharmaceuticals | Advancing the Potential Treatment of Alopecia Areata

Adds Deuruxolitinib, a Potential Best-in-Class Oral JAK Inhibitor for the Treatment of Alopecia Areata, an Autoimmune Dermatological Disease Leverages Sun ...

Source: zazoom.it